
Voyager Therapeutics Inc
NASDAQ:VYGR

Intrinsic Value
The intrinsic value of one
VYGR
stock under the Base Case scenario is
4.62
USD.
Compared to the current market price of 3.09 USD,
Voyager Therapeutics Inc
is
Undervalued by 33%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Voyager Therapeutics Inc
Fundamental Analysis


Revenue & Expenses Breakdown
Voyager Therapeutics Inc
Balance Sheet Decomposition
Voyager Therapeutics Inc
Current Assets | 276.8m |
Cash & Short-Term Investments | 266.7m |
Receivables | 2.2m |
Other Current Assets | 7.9m |
Non-Current Assets | 116.2m |
Long-Term Investments | 65.7m |
PP&E | 47.7m |
Other Non-Current Assets | 2.9m |
Free Cash Flow Analysis
Voyager Therapeutics Inc
USD | |
Free Cash Flow | USD |
Earnings Waterfall
Voyager Therapeutics Inc
Revenue
|
80m
USD
|
Operating Expenses
|
-160.5m
USD
|
Operating Income
|
-80.5m
USD
|
Other Expenses
|
15.5m
USD
|
Net Income
|
-65m
USD
|
VYGR Profitability Score
Profitability Due Diligence
Voyager Therapeutics Inc's profitability score is 38/100. The higher the profitability score, the more profitable the company is.

Score
Voyager Therapeutics Inc's profitability score is 38/100. The higher the profitability score, the more profitable the company is.
VYGR Solvency Score
Solvency Due Diligence
Voyager Therapeutics Inc's solvency score is 61/100. The higher the solvency score, the more solvent the company is.

Score
Voyager Therapeutics Inc's solvency score is 61/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
VYGR Price Targets Summary
Voyager Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for
VYGR
is 13.9 USD
with a low forecast of 9.09 USD and a high forecast of 18.9 USD.
Dividends
Current shareholder yield for VYGR is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
VYGR
stock under the Base Case scenario is
4.62
USD.
Compared to the current market price of 3.09 USD,
Voyager Therapeutics Inc
is
Undervalued by 33%.